Venous Thromboembolism (VTE) Clinical Trials

Find Venous Thromboembolism (VTE) Clinical Trials Near You

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

Status: Recruiting
Location: See all (51) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

This study is researching an experimental drug called REGN7508 (called study drug) and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thromboembolism (VTE) and other related diseases after total knee replacement surgery compared to acetylsalicylic acid. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Is undergoing a primary elective unilateral TKA

• Is in good health based on laboratory safety testing as described in the protocol

Locations
United States
California
Horizon Clinical Research
RECRUITING
La Mesa
Eisenhower Medical Center
RECRUITING
Rancho Mirage
CARI Clinical Trials
RECRUITING
Riverside
Colorado
HCA HealthONE Centennial
RECRUITING
Englewood
HCA HealthONE, HCA HealthONE Sky Ridge
RECRUITING
Lone Tree
Florida
South Florida Joint Replacement Center
RECRUITING
Deerfield Beach
Delray Physician Care Center
RECRUITING
Delray Beach
Medical Research of Westchester - MPLUS Research Network
RECRUITING
Miami
Larkin Community Hospital South Miami
RECRUITING
South Miami
Phoenix Clinical Research
RECRUITING
Tamarac
Illinois
Endeavor Health
RECRUITING
Skokie
Indiana
The Orthopaedic Research Foundation, Inc.
RECRUITING
Indianapolis
Kansas
NextStage Clinical Research, St. Francis Medical Park
RECRUITING
Wichita
Massachusetts
Boston Medical Center
RECRUITING
Boston
Tufts Medical Center
RECRUITING
Boston
Maryland
Velocity Clinical Research, Annapolis
RECRUITING
Annapolis
Sinai Hospital of Baltimore, Inc.
RECRUITING
Baltimore
North Carolina
Atrium Health Musculoskeletal Institute and Sports Medicine
RECRUITING
Charlotte
Duke University Health System (Duke Health), Duke University Hospital
RECRUITING
Durham
Eximia Equihealth Research-Raleigh. LLC
RECRUITING
Raleigh
The Vein and Vascular Center at Raleigh Radiology
RECRUITING
Raleigh
Coastal Vascular Institute, PA
RECRUITING
Wilmington
New Jersey
Holy Name Medical Center
RECRUITING
Teaneck
New York
Northwell Orthopaedic Institute
RECRUITING
New York
University of Rochester Medical Center
RECRUITING
Rochester
UBMD Orthopaedics and Sports Medicine
RECRUITING
Williamsville
Ohio
University of Cincinnati
RECRUITING
Cincinnati
Ohio Clinical Trials
RECRUITING
Columbus
The Ohio State University Wexner Medical Center
RECRUITING
Columbus
Pennsylvania
Penn State Health Milton S. Hershey Medical Center
RECRUITING
Hershey
University of Pittsburgh
RECRUITING
Pittsburgh
Texas
HD Research - Memorial Hermann Village
COMPLETED
Houston
NextStage Clinical Research, All American Orthopedics and Sports Medicine
RECRUITING
Houston
Endeavor Clinical Trials
WITHDRAWN
San Antonio
Flourish Research - San Antonio (Formerly Clinical Trials of Texas)
RECRUITING
San Antonio
Utah
DRx Clinical Research, LLC
RECRUITING
St. George
Virginia
Carilion Clinic
RECRUITING
Roanoke
Washington
Spokane Joint Replacement Center
RECRUITING
Spokane
Other Locations
Greece
Henry Dunant Hospital Center
RECRUITING
Athens
National and Kapodistrian University of Athens, General Hospital of Nea Ionia Konstantopouleio Patision
RECRUITING
Nea Ionia
Malaysia
Hospital Pakar Universiti Sains Malaysia
RECRUITING
Kota Bharu
Hospital Queen Elizabeth II
RECRUITING
Kota Kinabalu
Hospital Tengku Ampuan Afzan (HTTA)
RECRUITING
Kuantan
Sultan Abdul Halim Hospital
RECRUITING
Sungai Petani
Republic of Moldova
PMSI Emergency Medicine Institute
RECRUITING
Chisinau
Spain
Hospital Clinic Barcelona
RECRUITING
Barcelona
Hospital Universitario Infanta Leonor
RECRUITING
Madrid
Hospital Universitario Costa del Sol
RECRUITING
Marbella
Clinica Universidad de Navarra
RECRUITING
Pamplona
Hospital Clinico Universitario de Valencia
RECRUITING
Valencia
Hospital Miks Ospitalea
RECRUITING
Vitoria-gasteiz
Contact Information
Primary
Clinical Trials Administrator
clinicaltrials@regeneron.com
844-734-6643
Time Frame
Start Date: 2025-11-24
Estimated Completion Date: 2027-07-16
Participants
Target number of participants: 2000
Treatments
Experimental: REGN7508 and Placebo
Active_comparator: Placebo and ASA
Sponsors
Leads: Regeneron Pharmaceuticals

This content was sourced from clinicaltrials.gov

Similar Clinical Trials